Arm A: Gedatolisib + Palbociclib or Ribociclib + Fulvestrant Clinical Trials

1 actively recruiting trial across 1 location

Also known as: PF-05212384, IBRANCE, KISQALI®, Faslodex

Filter by location:

Duarte, California1 trial

Phase 3 Study of Gedatolisib as First-Line Treatment for Patients With HR-Positive, HER2-Negative Advanced Breast Cancer (VIKTORIA-2)

City of Hope Medical Center

Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.